Evaluation of the TheraNova Neuromodulation System to Provide Durable Relief of Overactive Bladder Symptoms
Clinical trial NCT05162833 · COMPLETED
Trial details
- NCT number
- NCT05162833
- Sponsor
- Theranova, L.L.C.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-20
- Primary completion
- 2023-12-08
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.